Brooks Automation reported strong financial results for Q4 2021, with revenue from continuing operations up 27% year over year. The company's Life Sciences business delivered another quarter of growth in excess of 20%.
Revenue from continuing operations for the fourth quarter was $137 million, up 27% year over year driven by strong growth in both Life Sciences Products and Services. Year-over-year organic growth was 24%.
Revenue from Life Science Products grew 38% year over year, and Life Sciences Services grew 20%.
Operating loss for the quarter was $21 million and gross margin was 48.3%.
Total diluted EPS of $0.29 includes $0.59 of diluted EPS from discontinued operations. Diluted loss per share from continuing operations was $0.30 per share, down $0.29 compared to the fourth quarter of 2020.
The Company announced revenue and earnings guidance for continuing operations for the first quarter of fiscal 2022. Revenue is expected to be in the range of $130 million to $140 million and GAAP diluted loss per share for the first fiscal quarter is expected to be in the range of $0.14 to $0.06. Non-GAAP diluted earnings per share from continuing operations is expected to be in the range of $0.04 to $0.12.